Current Funding Opportunities

Indo-U.S. Vaccine Action Program (VAP) Initiative on Tuberculosis (TB) Research: Regional Prospective Observational Research for Tuberculosis

Deadline: Jun 15, 2012 17:00 Eastern

CRDF Global, in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), the Indian Department of Biotechnology, the Indian Council of Medical Research (ICMR) and the NIH Office of AIDS research (OAR), announces a new funding opportunity for joint teams of U.S. and Indian scientists working in tuberculosis research.

This announcement invites applications from Indian and U.S.-based investigators working in the field of Tuberculosis (TB) clinical or biomedical research, to submit collaborative Indian-U.S. Letters of Intent (LOIs) as outlined in the announcement. The vision or aim of this initiative is to build and enhance biomedical and clinical research capacity in India by establishing long-term longitudinal cohorts of TB patients and their contacts (or other high TB risk patients) for studies using state-of-the art research tools. Similar cohorts may also be established in other high-burden countries, and in the future a collaborative global network of these cohorts might be utilized to undertake coordinated research to better understand similarities and differences in the TB epidemic in high-burden countries and to facilitate a broad array of biomedical TB research.

These awards are funded jointly by the Government of India’s (GOI) Department of Biotechnology, (DBT), the Indian Council of Medical Research (ICMR), and CRDF Global [utilizing funds provided by the U.S. National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) and NIH’s Office of AIDS Research (OAR)].

CRDF Global will address all program-related inquiries, receive/review Letters of Intent (LOIs), and communicate all results to applicants. CRDF Global will also receive full proposals from selected applicants and will coordinate the peer review.  A secondary review will be undertaken by the Joint Working Group (JWG) of the Indo-U.S. Vaccine Action Program (VAP).  Following these reviews, the most meritorious applications will be awarded for implementation.

Please submit completed LOIs as attachments to: TBCohort@crdfglobal.org. You may download the application template from the link below.

For more information about the program, please see the attached Program Announcement: India US TB Cohort RFP

LOI Template to be submitted to CRDF Global: NIAID INDIA LOI Template

Contact us: TBCohort@crdfglobal.org

Applicant Resources:

Frequently asked questions regarding this program: https://groups.google.com/forum/?fromgroups#!forum/tbcohortfaq

Collaborator solicitation tool: https://groups.google.com/forum/?fromgroups#!forum/tbcohortcollaborators